CONMED (CNMD) PT Raised to $158 at Needham & Company

October 28, 2021 6:22 AM

Needham & Company analyst Mike Matson raised the price target on CONMED (NASDAQ: CNMD) to $158.00 (from $150.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found